List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #941 to #990.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. ARIES 1 and 2 → Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
  2. ARISE → Aggressive Reduction Of Inflammation Stops Events
  3. ARI Sodium Iodide (I123) 1-12 MBq → Sodium iodide
  4. ARI Sodium Iodide (I123) 100-750 MBq → Sodium iodide
  5. ARMS → Apsac Reocclusion Multicenter Study
  6. ARMYDA → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
  7. ARMYDA-2 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
  8. ARMYDA-3 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
  9. ARMYDA-4 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
  10. ARMYDA-5 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
  11. ARMYDA-ACS → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
  12. ARMYDA-RECAPTURE → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
  13. ARMYDA-RELOAD → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
  14. ARNT gene → Aryl hydrocarbon receptor nuclear translocator
  15. ARPEGGIO → Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
  16. ARPKD → Polycystic kidney disease
  17. ARR → Absolute risk reduction
  18. ART → AIDS antiretroviral drugs
  19. ARTIST → Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
  20. ARTISTIC → Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary
  21. ARTS → Arterial Revascularization Therapies Study
  22. ARTS-II → Arterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
  23. ARTS I - Five year follow-up → Five Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
  24. ARVC → Arrhythmogenic right ventricular dysplasia
  25. ARVD → Arrhythmogenic right ventricular dysplasia
  26. ARVD/C → Arrhythmogenic right ventricular dysplasia
  27. AR Deficiency → Androgen insensitivity syndrome
  28. AR deficiency → Androgen insensitivity syndrome
  29. ASA → Aspirin
  30. ASAP → Effect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia
  31. ASA physical status class → Conscious sedation#ASA Physical Status Classification
  32. ASA physical status classification → Conscious sedation#ASA Physical Status Classification
  33. ASCENT → Acs Stent Clinical Equivalence In De Novo Lesions Trial
  34. ASCOT → Anglo-Scandinavian Cardiac Outcome Trial
  35. ASCOT-LLA Trial → ASCOT-LLA
  36. ASCOT - Blood Pressure Arm → Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
  37. ASCOT - Lipid Arm → ASCOT-LLA
  38. ASCVD → CAD
  39. ASD → Atrial septal defect
  40. ASFAST → Atherosclerosis And Folic Acid Supplementation Trial
  41. ASH → Hypertrophic cardiomyopathy
  42. ASIS → Angina And Silent Ischemia Study
  43. ASL (gene) → Argininosuccinate lyase
  44. ASMA → Anti-SM antibody
  45. ASO → Antistreptococcal antibodies
  46. ASO titer → Antistreptolysin O titer
  47. ASPAC → Asian-Pacific Collaboration On Chd Risk Factor Intervention
  48. ASPA (gene) → Aspartoacylase
  49. ASPECT-2 → Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
  50. ASPEN → ASPEN Trial

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"